Lombard Medical Stock Net Income
| EVARF Stock | USD 0.0001 0.00 0.00% |
Lombard Medical technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.
Lombard Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Lombard Medical's valuation are provided below:Lombard Medical does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Lombard |
Lombard Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lombard Medical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lombard Medical.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Lombard Medical on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Lombard Medical or generate 0.0% return on investment in Lombard Medical over 90 days. Lombard Medical is related to or competes with EnVVeno Medical. Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for t... More
Lombard Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lombard Medical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lombard Medical upside and downside potential and time the market with a certain degree of confidence.
Lombard Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lombard Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lombard Medical's standard deviation. In reality, there are many statistical measures that can use Lombard Medical historical prices to predict the future Lombard Medical's volatility.Lombard Medical Backtested Returns
We have found three technical indicators for Lombard Medical, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Lombard Medical are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Lombard Medical has perfect predictability. Overlapping area represents the amount of predictability between Lombard Medical time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lombard Medical price movement. The serial correlation of 1.0 indicates that 100.0% of current Lombard Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Lombard Medical reported net income of (31.04 Million). This is 109.09% lower than that of the Health Care Equipment & Supplies sector and 113.03% lower than that of the Health Care industry. The net income for all United States stocks is 105.44% higher than that of the company.
Lombard Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lombard Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Lombard Medical could also be used in its relative valuation, which is a method of valuing Lombard Medical by comparing valuation metrics of similar companies.Lombard Medical is currently under evaluation in net income category among its peers.
Lombard Fundamentals
| Return On Equity | -1.09 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (2.55) % | |||
| Operating Margin | (2.10) % | |||
| Current Valuation | 11.76 M | |||
| Shares Outstanding | 27.95 M | |||
| Number Of Shares Shorted | 34.67 K | |||
| Price To Sales | 0.02 X | |||
| Revenue | 12.17 M | |||
| Gross Profit | 1.14 M | |||
| EBITDA | (24.22 M) | |||
| Net Income | (31.04 M) | |||
| Cash And Equivalents | 20.8 M | |||
| Cash Per Share | 0.74 X | |||
| Total Debt | 30.29 M | |||
| Debt To Equity | 2.47 % | |||
| Current Ratio | 3.33 X | |||
| Book Value Per Share | 0.50 X | |||
| Cash Flow From Operations | (25.2 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | (1.54) X | |||
| Target Price | 1.0 | |||
| Number Of Employees | 113 | |||
| Beta | 4.89 | |||
| Market Capitalization | 2.65 K | |||
| Total Asset | 67.77 M | |||
| Net Asset | 67.77 M |
About Lombard Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lombard Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lombard Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lombard Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Lombard Pink Sheet
Lombard Medical financial ratios help investors to determine whether Lombard Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lombard with respect to the benefits of owning Lombard Medical security.